Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%
Genmab Stock (OTC:GNMSF), Key Statistics
Genmab Stock (OTC: GNMSF) analysis, key statistics.
Valuation Measures
Enterprise Value
19.2B
Trailing P/E
33.38
Forward P/E
25.71
PE Ratio (TTM)
27.77
PEG Ratio (TTM)
1.61
Price / Sales (ttm)
9.68
Price / Book (mrq)
5.46
Price / EBITDA
26.56
Enterprise Value / EBITDA (TTM)
22.72
Earnings Yield
3%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
62.35
Tangible Book value per share
62.07
Total Liabilities (Quarterly)
3.2B
Total Assets
32B
Total Liabilities
3.2B
Profitability
Net income Growth
-0.28
Gross Margin
- -
Net Margin
32.32%
EBIT Margin
41.21%
EBITDA Margin
41.21%
Operating Margin
35.66%